FDA Person
FDAYaharn Su
View detailed information about Yaharn Su, including compliance records, violations, and related data.
Person Profile
FDA investigator. Took part in 23 inspections of 23 companies, 2023–2026.
Inspections (23)
| Date | Company | Classification | Project area | Inspection |
|---|---|---|---|---|
| September 24, 2026 | Indivior UK Limited | Not classified | #1343906 | |
| September 18, 2026 | MW Encap Ltd.(NextPharma Edinburgh) | Not classified | Drug Quality Assurance | #1336234 |
| September 11, 2026 | Ferring Controlled Therapeutics, Ltd. | Not classified | #1345014 | |
| June 26, 2026 | AstraZeneca Pharmaceuticals, LP | Not classified | Drug Quality Assurance | #1327360 |
| April 7, 2026 | ChemPacific Corporation | Not classified | #1315036 | |
| February 13, 2026 | New Life Pharma LLC | Not classified | Drug Quality Assurance | #1300498 |
| October 31, 2025 | Carnegie Pharmaceutical Llc | NAI | Drug Quality Assurance | #1292782 |
| September 24, 2025 | Holland Company, Inc. | NAI | Drug Quality Assurance | #1287682 |
| August 14, 2025 | University Of Pittsburgh Medical Center (Centralized Packaging (CPAK)) | OAI | Drug Quality Assurance | #1278396 |
| June 24, 2025 | International Paper Company | Not classified | #1275726 | |
| May 16, 2025 | STAQ Pharma of Ohio, LLC | VAI | Drug Quality Assurance | #1270348 |
| March 27, 2025 | Noxell Corporation | NAI | Drug Quality Assurance | #1266978 |
| February 27, 2025 | C-Care, LLC | Not classified | Drug Quality Assurance | #1259748 |
| January 31, 2025 | Packaging Coordinators, LLC | Not classified | #1252349 | |
| October 25, 2024 | Church & Dwight Co., Inc. | VAI | Drug Quality Assurance | #1251801 |
| September 6, 2024 | Annovex Pharma, Inc. | OAI | Drug Quality Assurance | #1248991 |
| May 16, 2024 | Diamond Chemical Co. Inc. | OAI | Drug Quality Assurance | #1241183 |
| April 9, 2024 | Eisai, Inc. | VAI | New Drug Evaluation | #1237510 |
| March 8, 2024 | Sure-Biochem Laboratories, LLC | OAI | Drug Quality Assurance | #1232748 |
| December 15, 2023 | Granules Pharmaceuticals Inc. | VAI | Drug Quality Assurance | #1225087 |
Documents (13)
- 483 · STAQ Pharma of Ohio, LLC · May 16, 2025
- 483 · Annovex Pharma, Inc. · September 6, 2024
- 483 · Sure-Biochem Laboratories, LLC · March 8, 2024
- 483 · Granules Pharmaceuticals Inc. · December 15, 2023
- 483 · University Of Pittsburgh Medical Center (Centralized Packaging (CPAK)) · August 14, 2025
- 483 · Packaging Coordinators, LLC · January 31, 2025
- 483 · Church & Dwight Co., Inc. · October 25, 2024
- 483 · Eisai, Inc. · April 9, 2024
- 483 · WES Pharma Inc. · November 21, 2023
- 483 · C-Care, LLC · February 27, 2025
- 483 · New Life Pharma LLC · February 13, 2026
- 483 · ChemPacific Corporation · April 7, 2026
- 483 · AstraZeneca Pharmaceuticals, LP · June 26, 2026
Frequently inspected with (10)
James R. Birkenstamm
4 shared
Azeezat M. Lawal
3 shared
Pushpa S. Jayasekara
Investigator
3 shared
Tekalign Wondimu
Drug Investigator
3 shared
Christina K. Theodorou
Consumer Safety Officer
2 shared
Johnny D. Nwankwo
2 shared
Michael O. Idowu
issuing_officer
2 shared
Ogechi C. Nna
2 shared
Stephenie M. Ortiz
2 shared
Alisha B. Patel
1 shared
Person Information
Name
Yaharn Su
ID: 75b7f7fd-d853-436e-b538-386a8c6df3cb
Get More Insights
Access our comprehensive quality intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
1.5M+ regulatory data points
Real-time compliance monitoring
Interactive analytics dashboard
Looking for more people? Our platform provides access to thousands of FDA people with advanced search and filtering capabilities.
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.